distribution of Ii-p10 and of MHC class II. For this purpose, we made use of a new inhibitor of cathepsin S, N-morpholinurea-leucine-homophenylalanine -vinylsulfone-phenyl (LHVS) (Riese et al., 1996; Villadangos et al., 1997) . At nanomolar concentrations, LHVS is far more selective for cathepsin S than for other cysteine proteases (65-fold Ͼ cathepsin L; 6000-fold Ͼ cathepsin B), making it a far more specific probe than leupeptin.
Treatment of late DCs with 2-5 nM LHVS resulted in the accumulation of p10-␣␤ complexes. After pulselabeling, a 10 kDa protein, corresponding to Ii-p10, was coprecipitated with anti-class II antibodies beginning at In untreated late DCs, p10-␣␤ complexes were barely marrow-derived DCs were fractionated using a 25% Percoll density detectable, appearing transiently between 1 and 6 hr gradient. Membranes were pelleted from each fraction, separated on a 15% SDS-PAGE gel, and transferred to nitrocellulose mem-(left panel).
branes. Ii chain was detected with a cytoplasmic tail specific monoTo determine whether the LHVS-mediated inhibition clonal antibody (IN1). Ii chain isoforms p31 and p41 accumulated of Ii chain processing resulted in the relocalization of in low density fractions (ER) of early and late DCs. However, the MHC class II, late DCs were treated with 5 nM LHVS for proteolytic fragment Ii-p10 was only found in the heavy density 12 hr, homogenized, and then centrifuged in a Percoll lysosomes of early DCs (indicated by ␤-hexosaminidase activity, double arrow). Only traces of Ii-p10 were detected in the low density gradient. In control late DCs, MHC class II was restricted fractions of the late DCs.
to the low density region of the gradient, consistent with the known localization of ␣␤ dimers on the surface of Results these cells ( Figure 2B , top panel, fractions 18-23). In the LHVS-treated late DCs, however, accumulation of class Ii-p10 Accumulates in the Lysosomes II molecules was detected in the heavy density regions, of Immature DCs cosedimenting with the lysosomal marker ␤-hexosaminTreatment of cells with the general cysteine protease idase ( Figure 2B , lower panel). inhibitor leupeptin promotes the accumulation of the The MHC class II molecules that appeared in lysop10-␣␤ complexes (Neefjes and Ploegh, 1992 ; Amigosomal fractions due to LHVS corresponded to newly rena et al., 1995) . In A20 B cells, this results in the redistrisynthesized molecules as opposed to class II derived bution of class II molecules to lysosomes (Brachet et from the cell surface. This was demonstrated by blotting al., 1997) due to the lysosomal targeting signal provided Percoll gradient fractions from late DCs treated with by the Ii chain cytoplasmic tail (Odorizzi et al., 1994) .
both LHVS and cycloheximide. For convenience, gradiWe asked whether an analogous mechanism might exent fractions were combined into heavy (H), intermediate plain the different abilities of early and late DCs to accu-(I), and low (L) density pools. As expected, little class II mulate class II molecules in lysosomes.
␤ chain was detected in the heavy or intermediate pools Percoll gradient centrifugation was performed on from control cells, unlike LHVS-treated cells. Cyclohexipreparations of bone marrow derived early and late (mamide treatment completely prevented the appearance tured in presence of LPS) DCs. Ii chain distribution was of class II in the lysosomal fractions in LHVS-treated determined by immunoblotting using the cytoplasmic cells. Similar results were obtained when the pooled tail-specific monoclonal antibody IN1 (Figure 1 ). Early gradient fractions were blotted for Ii chain ( Figure 2C , and late DCs expressed comparable amounts of the p31 bottom panel). Ii-p10 was only found in cells treated and p41 isoforms of Ii chain, the two differing by a 10 with LHVS in the absence of cycloheximide and was kDa insertion distal to the CLIP domain (Cresswell, detected in only the heavy and intermediate fractions. 1996) . Both isoforms were largely found in low density Thus, LHVS only inhibited the processing and targeting fractions (containing the ER, Golgi, and plasma memof newly synthesized Ii chain and class II. branes) and most likely reflected Ii chain retained in the The fractionation results were confirmed by confocal ER, as this is where much new Ii chain accumulates in microscopy. As found previously, control mature DCs DCs and other APCs (Marks et al., 1990) . Early DCs also exhibited the majority of their class II (green) on the contained significant amounts of Ii-p10 but in heavy plasma membrane, with little if any class II detectable density lysosomal fractions. Relatively little Ii-p10 was in lgp/lamp-positive lysosomes (red) ( Figure 2D ). After found in late DCs and only in low density fractions. These LHVS treatment, class II molecules were detected on results were confirmed by confocal microscopy (data the plasma membrane but also in lysosomes, which now not shown) and suggested that DCs developmentally stained yellow ( Figure 2E ). Treatment with both LHVS regulate Ii chain processing, which, in turn, may control and cycloheximide prevented the relocalization of class the distribution of MHC class II molecules.
II molecules to lysosomes ( Figure 2F (L, 17-24) membranes and then immunoblotted for MHC class II and Ii chain. As observed in (B), control late DCs did not accumulate MHC class II in the lysosomes (H) in contrast to the lysosomal accumulation in LHVS-treated cells. However, DCs treated with both LHVS and cycloheximide did not accumulate class II in the heavy density fractions. In LHVS-treated DCs, p31 and p41 were found (using IN1) in the light fractions of the gradient (L), while Ii-p10 was mainly detected in the lysosomes (H) of LHVS-treated DCs (Ii-p10 appears as a doublet due to the fact that the gels were loaded twice to accommodate the large sample size [only low molecular weight bands were affected]). (D) Confocal immunofluorescence microscopy of control late DCs stained for MHC class II in green and lamp 2 in red. Class II molecules accumulated on the plasma membrane and were absent from lysosomes (MIIC). (E) Confocal immunofluorescence microscopy of LHVS-treated late DCs stained for MHC class II in green and lamp 2 in red. In presence of LHVS, MHC class II accumulated in lysosomes (MIIC), which thus stained yellow. The upper panel shows a thin confocal section (0.5 m) to best illustrate intracellular staining while reducing plasma membrane-derived background. The lower panel is a thicker optical section demonstrating the abundance of class II remaining on the cell surface. (F) Confocal immunofluorescence microscopy of LHVS/cycloheximide-treated late DCs stained for MHC class II in green and lamp 2 in red. MHC class II accumulated on the plasma membrane and was clearly absent from lysosomes (MIIC). Bar, 100 m.
Invariant Chain Degradation Is Developmentally
DCs, however, a strong Ii-p10 proteolytic activity (bottom panel) was detected in the heavy density, lysosomal Regulated in DCs To determine whether early and late DCs differed in their fractions (lanes 2 and 3). Ii-p10 was cleaved ‫-01ف‬fold more efficiently in the lysosomes of late DCs than in capacity for Ii chain processing, we devised an in vitro assay to measure the degradation of Ii-p10. As subthose of early DCs ( Figure 3C ). This developmental regulation of Ii-p10 degradation was not due to obvious difstrate, 35 S-labeled p10-␣␤ complexes were prepared from LHVS-treated, I-A b -transfected A20 B cells (Braferences in amount of membranes or lysosomes between early and late DCs; equivalent numbers of cells chet et al., 1997). The labeled complexes were incubated with fractions from Percoll gradients of unlabeled early yielded comparable amounts of protein and ␤-hexosaminidase activity in the fractions (data not shown). or late DCs, and the ability of each fraction to degrade the Ii-p10 was monitored by SDS-PAGE.
To determine whether cathepsin S was responsible for the developmentally regulated proteolysis, we examAs shown in Figure 3A (top panel), in fractions prepared from early DCs, no obvious degradation of Ii-p10 ined the sensitivity of the lysosomal Ii-p10 processing activity to LHVS. Lysosomal fractions from late DCs could be detected even after 2 hr of incubation. In late were incubated with p10-␣␤ complexes in various conearly and late DCs were probed by immunoblot using an antibody to cathepsin S, similar amounts of the protease centration of LHVS. As shown in Figure 3B , p10 degradation was strongly (75%-80%) inhibited at 2 nM LHVS.
were found in both samples. Since this result did not reflect differences in cell protein, either the regulation Little if any further inhibition was obtained at LHVS concentrations up to 200 nM. At 2 nM, LHVS is highly of another as yet unknown protease was responsible for the increase in Ii-p10 processing activity, or the activselective for cathepsin S, while at 200 nM cathepsin L is also inhibited (Riese et al., 1996) . Although cathepsin ity of cathepsin S was regulated indirectly. We explored the latter possibility. L also efficiently degrades Ii chain, it is active primarily in thymic epithelial cells rather than DCs (Nakagawa et Members of the three subgroups forming the cystatin superfamily are all potent inhibitors of cysteine proteal., 1998). Similarly, neither cathepsin B nor D plays an important role in Ii chain processing (Deussing et al., ases (Barrett, 1987; Turk and Bode, 1991; Henskens et al., 1996) . Family 1 (cystatins A and B) are cytosolic, 1998). Thus, it is likely that cathepsin S is responsible for most Ii chain processing in DCs.
while cystatins from family 2 (C, E, and S) and 3 (kininogens) are secreted and found in most biological fluids (Abrahamson et al., 1986) . Cystatin C (␥-trace, 13 kDa) Regulation of Cathepsin S and Its Endogenous Inhibitor Cystatin C during DC Maturation is the best known of all the secreted inhibitors and is a potent inhibitor of cathepsins S (K i ϭ 1 ϫ 10
Ϫ12
) and L We next asked whether the Ii-p10 processing activity in late DCs reflected an increase in cathepsin S expression. (Brö mme et al., 1991; Henskens et al., 1996; Leonardi et al., 1996) . Cystatin C is secreted by mononuclear This proved not to be the case (Figure 4 , left). When (Left panel) Equivalent amounts of early and late bone marrow-derived DCs extracts were separated by 15% SDS-PAGE and transferred to nitrocellulose. Cathepsin S was detected by immunoblot with a rabbit polyclonal anti-human cathepsin S antibody that crossreacted with mouse cathepsin S. Tubulin was detected with the rabbit anti-tubulin antibody T13. The equivalent quantities of tubulin detected indicated that equal amounts of protein were transferred, as did the equivalent levels of an unknown 40 kDa cross-reactive band. Cathepsin S levels detected in early and late DCs were equivalent in multiple experiments. (Right panel) The same immunoblot was used to detect the cysteine protease inhibitor cystatin C (13 kDa) as well as a 15 kDa presumptive cystatin C isoform (arrows) using a rabbit polyclonal anti-human cystatin C that cross-reacts with mouse cystatin C. Quantitation of several blots indicated that cystatin C was down-regulated in late DCs by ‫3ف‬ fold; the 15 kDa band disappeared completely. (Bottom) When equivalent amounts of cystatin C were transferred (normalized by loading three times more late DC lysate than early DC lysate), the putative novel isoform of cystatin C was detected in early but not late DCs. (Left) Confocal immunofluorescence microscopy of immature LCs from mouse ear epidermal sheets stained for cystatin C (top) and MHC class II (M5114, bottom). Cystatin C was found to colocalize with class II (arrows) in lysosomes (MIIC), demonstrating that cystatin C was selectively expressed by LCs and was apparently lysosomal. Surrounding keratinocytes were largely negative for cystatin C. (Right) Cystatin C staining was mostly lost from LCs induced to mature by incubation of epidermal sheets in LPS for 18 hr. Maturation promoted the down-regulation of cystatin C, while, as expected, MHC class II redistributed along the dendritic processes.
phagocytes (Warfel et al., 1987; Miyake et al., 1996) and structures in LCs appeared positive for both cystatin C and class II (arrows). Since class II is restricted to late has been thought to play a role in tissue remodeling.
Quantitative immunoblots revealed that both early and endosomes and lysosomes in these cells (Kleijmeer et al., 1994; Pierre et al., 1997) , it is likely that cystatin C was late DCs expressed 13 kDa cystatin C (Figure 4 , right panel). However, in late DCs, the amount of cystatin C also in late endocytic organelles. Upon LPS-induced maturation of LCs (right panels), there was a dramatic was reduced by ‫-3ف‬fold. Furthermore, a 15 kDa cystatin C isoform was present in early DCs and totally absent decrease in cystatin C staining concomitant with a redistribution of MHC class II to the plasma membrane (Pierre from the late DCs. The selective loss of the 15 kDa isoform was confirmed by normalizing the blots for the et al., 1997). These results confirm the ability of cystatin C to reach class II-containing compartments in early 13 kDa cystatin C isoform ( Figure 4B, bottom) . Although not dramatic, the fact that cystatin C acts as a stoichioLCs prior to maturation. To examine the distribution of cystatin C at higher resolution, we next examined its metric inhibitor of cathepsin S means that any decrease in the cystatin C to cathepsin S ratio may result in a localization in bone marrow-derived DCs. In early DCs ( Figure 6A , upper left panel), a significant substantial increase in active cathepsin S.
fraction of cystatin C was in class II-positive structures (arrowheads; yellow). Similar results were also obtained Cystatin C Localization during DC Maturation Since cystatin C has been characterized as a secretory when cystatin C was visualized together with Ii chain (data not shown). Thus, in immature cells, cystatin C was protein, it was necessary to determine whether it did accumulate intracellularly in immature DCs. We first exfound largely within class II-positive lysosomes (MIIC).
In late DCs ( Figure 6A , upper right), remaining intracelamined its localization in epidermal Langerhans cells (LCs), typical immature tissue DCs that can be induced lular cystatin C accumulated in the perinuclear cytoplasm, while most class II was at the surface. However, to mature in situ upon treatment with LPS.
When epidermal explants from mouse ears were the intracellular class II was no longer sequestered in lysosomes. In early or immature DCs, there was as exstained for cystatin C and MHC class II, intracellular cystatin C expression was detected but only in MHC pected good if incomplete colocalization between cystatin C and lamp 2, best illustrated by individual strucclass II-positive LCs ( Figure 5 , left panels). Keratinocytes expressed little if any cystatin C. Intracellular tures at the cell periphery (arrows; Figure 6A , lower left). (A) Early (immature) and late (mature) DCs were stained for cystatin C together with MHC class II (upper panels) or lamp 2 (lower panels). In early cells, there was extensive colocalization of cystatin C with both class II and lamp 2 in the perinuclear region and in the peripheral cytoplasm. Individual vesicles could be easily discerned in the periphery (arrows). However, cystatin C was absent from a minority of class II-positive organelles (green). In late DCs, little colocalization was observed, with most of the class II on the cell surface leaving cystatin C in class II-negative structures (Bars, 100 m). As shown in the lower right panel, these vesicles were also negative for lamp 2, showing that in these cells cystatin C was no longer in the endocytic pathway (blue arrows). To minimize the clustering of organelles around the MTOC, DCs were treated with reduced amount of LPS (20 ng/ml) during a shorter time (12 hr). These conditions facilitated a better detection of individual cystatin C or lamp2 containing organelles.
(B) Postnuclear supernatants of equal amounts of early and late bone marrow-derived DCs were fractionated using a 25% Percoll density gradient. The resulting fractions were pooled (heavy density, fractions 1-7; low density, fractions 17-24) and Western blotted for cystatin C and cathepsin S. Cathepsin S was found in the lysosomes of early and late DCs, while only a cross-reactive band of ‫54ف‬ kDa, probably pro-cathepsin S, was detected in the low density fractions. No differences were observed in the distribution of cathepsin S during DC maturation. Cystatin C was detected predominantly in the lysosomal fractions but only in early DCs. Upon maturation, the amount of cystatin C in the heavy density fractions was dramatically reduced. Although cystatin C was detected in low density fractions in late cells, even this amount was reduced relative to early DCs. Thus, cystatin C remaining intracellularly in DCs after maturation exhibited a marked shift in intracellular distribution, from high density lysosomes to low density membranes.
Upon DC maturation, lamp 2-positive lysosomes clus-DC maturation changes not only the level of cystatin C expression but also its intracellular distribution. tered in the perinuclear region but were devoid of cystatin C. Instead cystatin C was in lamp 2-negative peripheral structure (arrows; Figure 6A , lower right panel; dispersed due to low LPS treatment, see legend). These Cystatin C Overexpression Induces Class II Accumulation in the Lysosomes structures were positive for the Golgi-specific snail lectin Helix pomatia (Krijnse-Locker et al., 1994) , sugOur results thus far are clearly consistent with the regulation of cystatin C in controlling cathepsin S activity. gesting that cystatin C accumulates in the Golgi complex of late DCs (data not shown).
However, we have not directly demonstrated that alterations in cystatin C can explain the observed differences To further document the change in cystatin C localization, Percoll gradient centrifugation was performed on in Ii-p10 processing or MHC class II traffic. To obtain such evidence, we screened various class II-expressing early and late DCs. Western blot of pooled heavy density (lysosomal) and low density fractions confirmed that cell lines for cystatin C expression. Cell lines that localized significant amounts of MHC class II to lysosomes both isoforms of cystatin C accumulate in lysosomes of early but not late DCs; in contrast, the amount of cathep-(e.g., macrophages, the Pala human lymphoblast cell line) also exhibited high amounts of sin S in lysosomes (or low density membranes) was unchanged ( Figure 6B ). Some cystatin C was detected in cystatin C in endocytic organelles (data not shown).
Those that transported little class II to the lysosomes the low density fractions of both early and late DCs, consistent with a partial localization in the Golgi complex.
(e.g., A20 cells) expressed relatively low amounts of cystatin C. To demonstrate a relationship between cysThus, cystatin C is at least in part an intracellular protein that can reach the endocytic pathway, where it tatin C and class II transport, we asked whether increasing cystatin C levels in A20 cells could inhibit Ii chain must be to play a role in regulating cathepsin S activity. . The ability of transfected cells to accumulate Ii-p10 and to redistribute their class II molecules to lysotransfected with a cDNA encoding for mouse cystatin C (Solem et al., 1990) . We selected a clone expressing somes provides direct evidence that modest variations in cystatin C levels can exert significant effects on the 3-to 4-fold more than the untransfected control cells ( Figure 7A, bottom panel) , so that the difference in extraffic of MHC class II molecules. pression was similar to that seen in developing DCs. The transfectants still expressed less cystatin C than Discussion even late DCs on a per cell basis. However, cystatin C levels are only meaningful relative to levels of cathepsin The nature of the MHC class II-containing compartments has become a problem of intense interest (Watts, S or other targets.
Next, we determined the state of Ii chain in the 1997). Depending on the cell type examined, MHC class II can accumulate in conventional late endocytic comtransfected cells (Figure 7, top panel) . Although Ii chain (p31) levels were identical in the transfected and control partments (MIIC) (Kleijmeer et al., 1997) or in vesicles related to but distinct from early endosomes (CIIVs) cells, the slight overexpression of cystatin C significantly increased the accumulation of Ii-p10. Interestingly, the Drake et al., 1997) . Although the functions of these two compartments remain undegree of Ii-p10 accumulation was greater than in late DCs, which expressed comparable amounts of Ii chain clear, DCs are remarkable in that at different stages of development, they localize class II molecules first in (p31). Confocal microscopy confirmed that the cystatin C was localized to lamp 2-positive late endosomes and MIICs (lysosomes), in CIIVs, and finally on the cell surface (Pierre et al., 1997) . The alteration in class II traffic lysosomes (data not shown).
Control and transfected A20 B cells were then examis crucial, since the DC's capacity for antigen presentation is closely linked to these events. In early DCs, class II ined for the intracellular distribution of MHC class II molecules. As found previously (Brachet et al., 1997) , molecules targeted to lysosomes (MIIC) exhibit relatively short half-lives (t1⁄ 2 Ͻ 12 hr) and are poorly expressed control A20 cells exhibited the majority of their class II on the surface, with intracellular lamp 2-positive structures at the cell surface. Thus, early DCs can accumulate but not present antigen until induced to mature by inflammabeing generally negative for class II (Figure 7 , left panels). However, in the cystatin C transfectants, significant tory mediators (e.g., TNF␣ and LPS) and redirect class II to the plasma membrane. Thus, it was of interest to amounts of MHC class II were found in lamp 2-positive structures, which now stained yellow (right panels). By determine the mechanisms responsible for regulating class II transport. using different antibodies, the lysosomal redistribution , 1996) . Interestingly, cathepsin S exhibits a broad in bone marrow-derived APCs where cathepsin S is pH activity curve, being active even at neutral pH (Bohley thought to be primarily responsible (Riese et al., 1996; and Seglen, 1992) . Thus, the enzyme is likely to be active Cresswell, 1998; Nakagawa et al., 1998) . Accordingly, it even in early endocytic compartments, which may be seemed likely that in DCs, the cathepsin S was largely the points of entry of newly synthesized Ii-␣␤ complexes responsible for Ii-p10 processing, consistent with its coming from the Golgi. Alternatively, it is possible that sensitivity to low concentrations of LHVS. We were Ii chain processing and sorting occurs in late endocytic therefore surprised to find that the increase in Ii chain compartments or that Ii chain removal is needed to reprocessing activity upon maturation was not accompaverse an active retention of class II molecules in lysonied by an increase in cathepsin S. Rather, there was a somes. decrease in an endogenous inhibitor of cathepsin S, cystatin C. In addition, the intracellular distribution of Biology of Cystatin C cystatin C changed markedly, being found primarily in
The presence of the cysteine protease inhibitor cystatin endocytic organelles of immature cells and in the Golgi C in DCs and its down-regulation during maturation procomplex of mature cells. Since cystatin C is a stoichiovided an attractive solution to the developmental control metric inhibitor of cathepsin S, the partial reduction in of Ii degradation by cathepsin S. The fact that cystatin cystatin C levels combined with its depletion from endo-C is a secreted molecule, however, had always sugsomes and lysosomes seems sufficient to explain the gested a role in the control of extracellular proteolytic observed increase Ii-p10 processing activity upon DC activities (Knoch et al., 1994; Henskens et al., 1996) . maturation. This possibility received direct support from Although the ability of cystatin C to inhibit cysteine prothe cystatin C transfection experiments in which we teases in general, and cathepsin S in particular, has were able to induce Ii-p10 accumulation and lysosomal been carefully described and quantified, this activity transport of class II by increasing cystatin C levels in was believed to be performed extracellularly (Brö mme A20 cells by only 3-to 4-fold, very similar to the variation et al., 1991; Leonardi et al., 1996) . Indeed, cystatin C seen in developing DCs. Although we cannot formally forms dimers at acidic pH and therefore was thought to exclude that cystatin C-sensitive proteases other than be inactive in the late endocytic pathway, although dicathepsin S could be responsible for the regulated Ii rect evidence was never obtained (Ekiel and Abrahamchain degradation, cystatin C has a far greater specificson, 1996; Merz et al., 1997) . Our transfection experiity for cathepsins S and L than other known protease, ments of mouse cystatin C in A20 cells demonstrated and cathepsin L plays little if any role in DCs (Hall et al., that cystatin C can reach endocytic compartments and 1998).
inhibit cathepsin activity intracellularly, as indicated by How might the regulation of Ii chain cleavage control the accumulation of Ii-p10 in the transfectants. In addithe transport of MHC class II molecules? Initial clues tion, peptides derived from cystatin C could be eluted were suggested by experiments using the broad spec-MHC class II along with Ii-CLIP and class II peptides. trum protease inhibitor leupeptin. Leupeptin treatment This observation confirms that significant amounts of of B cell lines led to delayed Ii chain degradation and a cystatin C have access to the endocytic pathway of delay or complete inhibition of surface appearance of APCs and that cystatin C itself is a target for proteolysis class II molecules (Neefjes and Ploegh, 1992; Amigorena (Rudensky et al., 1991; Rider et al., 1996) . Indeed, cyset al., 1995; Brachet et al., 1997) . The inhibition could tatin C is known to be inactivated by proteolytic degraalso result in the accumulation of p10-␣␤ complexes in dation by cathepsin D and elastase (Abrahamson et al., lysosomes, even in cells that normally transport very 1991a, 1991b; Lenarcic et al., 1991) . little class II to late endocytic compartments. An attracUnderstanding how developing DCs control the tive explanation can be proposed based on our current amount and localization of cystatin C must await eluciunderstanding of the class II transport pathway. MHC dation of how cystatin C reaches the endocytic pathway. class II reaches endosomes by direct targeting from Relative to early DCs, mature DCs exhibit a limited cathe trans-Golgi network or by endocytosis from the cell pacity for endocytosis (Sallusto and Lanzavecchia, 1994 ; surface. Ii chain must then be rapidly cleaved and disso- Cella et al., 1997b) . Thus, secreted cystatin C might ciated for class II molecules to proceed from endosomes be internalized by immature but not by mature DCs as to the plasma membrane, since the Ii chain cytoplasmic already suggested for transfected CHO cells (Merz et domain contains a lysosomal targeting signal, which, if al., 1997). However, our finding that LCs in situ and not removed, targets the Ii-␣␤ complex to lysosomes. transfected B cells in culture localize cystatin C to endoInefficient Ii chain processing in endosomes, as would cytic organelles makes secretion-recapture an unlikely occur if active cathepsin S levels were low as in immamechanism. Thus, it is likely that the cystatin C observed ture DCs, would thus favor class II transport to lysoin DCs reached the endocytic pathway directly after somes. Enhancing active cathepsin S by decreasing exiting the Golgi. The mechanisms controlling cystatin cystatin C would increase the efficiency of Ii chain pro-C levels and targeting as well as the site at which cystatin cessing, thus rescuing newly arrived class II.
C interacts with cathepsin S and the possible signifiOne potential problem with this idea is that we were cance of the apparent 15 kDa cystatin C isoform are all questions that remain to be answered. only able to detect Ii-p10 processing activity in high
Experimental Procedures
(Pharmacia, Piscataway, NJ) at 4ЊC. Lysates were immunoprecipitated overnight with the Y3P anti-class II mAb and protein A-Sepharose. Sepharose pellets were washed three times in precipitation Materials Chemicals were purchased from Sigma (St. Louis, MO) unless stated buffer, once in PBS, and transferred to degradation assay buffer (50 mM Na acetate [pH 5.5], 1% Triton X-100, 3 mM cysteine, 1 mM otherwise.
EDTA). Fifteen microliters of the immunoprecipitated material (p10-Ii-␣␤ complexes) was used as substrate and incubated for 2-4 hr Cell Culture at 37ЊC with 30 l of DC membranes isolated after Percoll gradient Male BDF1 mice (7-8 weeks old, I-A b and I-A d -positive) were purcentrifugation. DCs (2-3 ϫ 10 7 ) were fractionated by Percoll gradient chased from Jackson Laboratories (Bar Harbor, Maine); bone mar-(as described above), and after high speed centrifugation of 500 l row-derived DCs and epidermal explants were cultured as defractions, pelleted membranes were resuspended in 15 l of assay scribed previously (Schuler and Steinman, 1985; Larsen et al., 1990;  buffer and pooled. After incubation, sample buffer was added and Inaba et al., 1992; Pierre et al., 1997) . Rabbit complement and monoelectrophoresis performed using 15% SDS-PAGE gels. Gels were clonal antibodies TIB120, GK1.5, TIB 211, and B220 were obtained quantified using Molecular Dynamics phosphorimager or by image from Pharmingen (San Diego, CA) or as hybridomas from ATCC digitization (Visage 2000; BioImage, Ann Arbor, MI). (Gaithersberg, MD). Recombinant murine GM-CSF was produced as a culture supernatant from J558L cells transfected with mGMPulse-Chase Radiolabeling Experiments CSF cDNA (a kind gift of Dr. D. Gray, London, UK). DC maturation Late DCs (3 ϫ 10 7 ) (18 hr treatment with LPS) were incubated in was induced by adding 100 ng/ml LPS to the cultures for 1-2 days. methionine-free media for 2 hr in presence of 5 nM LHVS, then were pulse-labeled with 10 mCi/ml of [ 35 S]-methionine Translabel (ICN Generation of Stable A20 Cell Transfectants Biochemicals, Costa Mesa, CA) for 20 min and chased for various Murine A20 B cells (B414, a kind gift of Charles Janeway, Yale) times at 37ЊC in RPMI/10% FCS with excess of methionine, cysteine, harboring the cDNAs encoding I-A b class II molecules (selected and LHVS. Radiolabeled cell pellets were lysed for 10 min on ice in with G418) were transfected with the eukaryotic expression vector 10 mM Tris 150 mM NaCl (pH 7.4) containing 1% TX-100 (Sigma), pMCFRhyg (20 g) carrying the cDNAs coding for mouse cystatin 0.5 mM PMSF, and protease inhibitor cocktails. Lysates were pre-C (ATCC #63116) (Solem et al., 1990 ) and a hydromycin resistance cleared with protein A-Sepharose (Pharmacia, Piscataway, NJ) at gene. Electroporation was performed with a Bio-Rad gene pulser 4ЊC. Lysates were immunoprecipitated overnight with the Y3P antiat 270 V and 500 F. The pMCFR expression vector was a gift of class II rat mAb and protein A-Sepharose. Tom Novak (Yale) (Denzin et al., 1994) . Cystatin C-transfected murine B414 cells were selected and grown in ␣-MEM, 7.5% FCS, 50
